Fig. 4From: Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New ZealandSensitivity and specificity reports. ROC curves using the development group (a), and the validation group (b); Detailed sensitivity & specificity report for individual cut-points using the development group (c), and the validation group (d)Back to article page